CA Patent

CA2495454C — Pharmaceutical compositions for inhalation containing a new anticholinergic in conjunction with corticosteroids and betamimetics

Assigned to Boehringer Ingelheim Pharma GmbH and Co KG · Expires 2011-09-06 · 15y expired

What this patent protects

The invention relates to novel medicament compositions based on a novel anticholinesterase drug, corticosteroids and betamimetic drugs, to methods for the production thereof, and to their use in the treatment of respiratory illnesses.

USPTO Abstract

The invention relates to novel medicament compositions based on a novel anticholinesterase drug, corticosteroids and betamimetic drugs, to methods for the production thereof, and to their use in the treatment of respiratory illnesses.

Drugs covered by this patent

Patent Metadata

Patent number
CA2495454C
Jurisdiction
CA
Classification
Expires
2011-09-06
Drug substance claim
No
Drug product claim
No
Assignee
Boehringer Ingelheim Pharma GmbH and Co KG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.